Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27353306 | 0.85 | CYP1A2 (0.36) | ALDH1A1 | |
| SCHEMBL13816479 | 0.85 | MAOA (0.41) | ALDH1A1 | |
| SCHEMBL25692683 | 0.85 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL13523401 | 0.85 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL23783891 | 0.84 | MAOA (0.38) | ALDH1A1 | |
| SCHEMBL18562521 | 0.81 | MEN1 (0.34) | — | |
| SCHEMBL17726107 | 0.81 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL21118275 | 0.81 | SLC6A2 (0.38) | — | |
| SCHEMBL3807753 | 0.81 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL17643182 | 0.81 | TRIM24 (0.36) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230271988-A1 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271988-A1 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | HPD, TALDO1, OGG1 | GLO1 1714/4885ALDH1A1 1554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.